EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients

Yuan Jian iD, Feifei Han, Ying Zhu iD, Chuanying Geng, Yanru Zhang, Yin Wu, Yun Leng, Wenming Chen, Zhuoling An, Hong-Hu Zhu

Clinical and Translational Science · 2024

DOI: 10.1111/cts.70006 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Yuan Jian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Sulfonamides, Bone Marrow. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Hospitals Authority Yangfan Project 3.0, "Dengfeng" Talent Training Program of Beijing Hospitals Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venetoclax, a small molecule inhibitor of BCL‐2, has demonstrated efficacy in treating acute leukemias and has been recommended as one of the first‐line anti‐leukemia therapies. Although venetoclax has been suggested to probably possess the ability to penetrate the central nervous system (CNS), current data to elucidate the characteristics of venetoclax in cerebrospinal fluid (CSF), bone marrow (BM), and plasma are still lacking. This study investigated the real‐world characteristics of venetoclax concentrations in CSF, BM, and plasma in acute leukemia patients. Thirteen acute leukemia patients treated with venetoclax were included, with paired samples of CSF, BM, and plasma collected and venetoclax concentrations measured using LC–MS/MS. With the results, the median venetoclax concentrations were 2030 ng/mL in plasma, 16.7 ng/mL in CSF, and 1390 ng/mL in BM. The percentages of CSF/plasma and BM/plasma were 0.74% and 70.37%, respectively. While no direct correlation was observed between CSF and plasma venetoclax levels, there was a trend toward an improved CSF/plasma percentage over time following the last administration of venetoclax. In contrast, a strong correlation was found between BM and plasma levels. This study demonstrated that venetoclax could reach its effective concentration in most patients, suggesting its potential clinical utility in the management of CNS involvement in acute leukemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bridged Bicyclo Compounds, HeterocyclicSulfonamidesBone MarrowHumansMaleMiddle AgedFemaleAgedAdultAntineoplastic AgentsTandem Mass SpectrometryLeukemia, Myeloid, AcuteAged, 80 and overChromatography, LiquidLeukemiaYoung Adult

Substanzen

venetoclaxBridged Bicyclo Compounds, HeterocyclicSulfonamidesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Chinese Institutes for Medical Research, Beijing, China.

ORCID-Profile: Yuan Jian, Ying Zhu

Förderung

  • Beijing Hospitals Authority Yangfan Project 3.0
  • "Dengfeng" Talent Training Program of Beijing Hospitals Authority

Zitieren

APA

Jian, Y., Han, F., Zhu, Y., Geng, C., Zhang, Y., Wu, Y., Leng, Y., Chen, W., An, Z., & Zhu, H. H. (2024). Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients. Clinical and Translational Science. https://doi.org/10.1111/cts.70006

Vancouver

Jian Y, Han F, Zhu Y, Geng C, Zhang Y, Wu Y, et al. Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients. Clinical and Translational Science. 2024. doi:10.1111/cts.70006

BibTeX
@article{Jian2024,
  author = {Jian, Yuan and Han, Feifei and Zhu, Ying and Geng, Chuanying and Zhang, Yanru and Wu, Yin and Leng, Yun and Chen, Wenming and An, Zhuoling and Zhu, Hong-Hu},
  title = {Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.70006}
}
Kostenlos starten →